Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
Salicylic acid; Lactic acid
Dermal Laboratories (Ireland) Limited
D11AF
Salicylic acid; Lactic acid
12.0 %w/w + 4.0 percent weight/weight
Gel
Wart and anti-corn preparations
Marketed
1989-11-21
PACKAGE LEAFLET: INFORMATION FOR THE USER SALATAC TM GEL 12.0% w/w salicylic acid, 4.0% w/w lactic acid READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS PRODUCT. Keep this leaflet. You may need to read it again. Ask your doctor or pharmacist if you need more information or advice. IN THIS LEAFLET: 1. What Salatac Gel is and what it is used for 2. Before you use Salatac Gel 3. How to use Salatac Gel 4. Possible side effects 5. How to store Salatac Gel 6. Further information 1. WHAT SALATAC GEL IS AND WHAT IT IS USED FOR Salatac Gel is a collodian wart paint for treating warts, verrucas, corns and calluses. - WARTS AND VERRUCAS are small excessive growths of skin caused by a type of virus. Warts often occur on the fingers, or on the back of the hands. You can recognise the common wart by the rough “cauliflower-like” appearance of the surface. Verrucas occur only on the sole of the foot. They can be painful, and often look like a small white ring of skin with a black dot in the centre. The virus is very infectious. This means that warts and verrucas can grow and spread, particularly if left untreated. The virus can also be transferred from one person to another. - CORNS AND CALLUSES are hard, thick pads of skin caused by pressure and friction. They usually occur on the feet due to poorly fitting shoes. They can also occur on the hands. Salatac Gel is suitable for use by ADULTS, CHILDREN AND THE ELDERLY . The ACTIVE INGREDIENTS in this product are salicylic acid and lactic acid. The active ingredients work by: - softening the hard skin growth, making it easier to remove with a pumice stone or emery board; - helping to kill the virus that causes warts and verrucas. 2. BEFORE YOU USE SALATAC GEL DO NOT USE Salatac Gel if you are ALLERGIC (hypersensitive) to salicylic acid, lactic acid or any of the other ingredients of Salatac Gel listed in Section 6. Do not use this product anywhere on or near your face, armpits, breasts, bottom or genital (sex) area. Do not use it on birthmar Lugege kogu dokumenti
Health Products Regulatory Authority 11 December 2020 CRN00C17S Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Salatac Gel Salicylic Acid 12.0% w/w Lactic Acid 4.0% w/w 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Salicylic acid 12.0 %w/w Lactic acid 4.0 % w/w For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Gel A clear viscous gel. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the topical treatment of warts, verrucas, corns and calluses. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For adults, children and the elderly. Salatac Gel should be applied once daily. The gel should be applied once every night. Treatment can take up to twelve (12) weeks for resistant lesions to disappear and it is necessary to persevere with the treatment. 1. Every night, soak the affected site in warm water for 2 to 3 minutes. 2. Dry thoroughly with the patient’s own towel. 3.Carefully apply one or two drops of the gel to the lesion and allow to dry over its surface. Take care to avoid spreading on to surrounding normal skin. No adhesive plaster is necessary. 4. The following evening, carefully remove and discard the elastic film formed from the previous application, and reapply the gel. Occasionally, if removal of the elastic film proves difficult, carefully reapply the gel directly over it and allow to dry. This should help thicken the film to assist removal. If necessary, such re-application may be made on two or three successive days. 5. Once a week, gently rub away the treated surface using an emery board, as provided, or pumice stone used only for this purpose, before re-applying the gel. 6. The wart, verruca, corn or callus may take up to twelve (12) weeks to disappear and it is important to persevere with the treatment. 7. At the end of treatment, if the elastic film is difficult to remove, it may be allowed to remain on the skin until it sheds. Health Products Regulatory Authority 11 December 2020 CRN00C17S Page 2 of 4 4.3 CONTRAINDICATIONS Not to be used on or near th Lugege kogu dokumenti